Related Experiment Video

Updated: Aug 11, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Childhood rhabdomyosarcoma

David Rodeberg1, Charles Paidas

  • 1Department of Pediatric Surgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Seminars in Pediatric Surgery
|February 7, 2006
PubMed

Insights

Rhabdomyosarcoma (RMS) is a childhood striated muscle tumor. Multimodality therapy has improved survival to over 70%, with prognosis depending on various clinical and biological factors.

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Molecular Biology

Background:

  • Rhabdomyosarcoma (RMS) is a malignant tumor originating from striated muscle, primarily affecting children.
  • Significant advancements in multimodality therapy have led to a greater than 70% 5-year survival rate for RMS.
  • Prognosis is influenced by primary tumor site, patient age, resection completeness, metastatic status, histology, and tumor biology.

Purpose of the Study:

  • To outline the critical role of pretreatment staging and postoperative clinical grouping in risk stratification for Rhabdomyosarcoma.
  • To emphasize the importance of surgical resection in improving survival outcomes for pediatric RMS patients.
  • To highlight the current treatment standards based on Children's Oncology Group protocols.

Main Methods:

  • Review of multimodality treatment protocols for Rhabdomyosarcoma.
  • Analysis of prognostic factors including tumor site, age, resection status, and metastatic burden.
  • Assessment of risk stratification strategies based on pretreatment stage and postoperative clinical grouping.

Main Results:

  • Multimodality therapy has achieved over 70% 5-year survival for Rhabdomyosarcoma.
  • Pretreatment staging (site, size, nodes, metastasis) is vital for treatment planning.
  • Postoperative clinical grouping, assessing resection completeness, significantly impacts survival.

Conclusions:

  • Complete surgical resection of Rhabdomyosarcoma, including microscopic disease, improves survival.
  • Surgeons play a crucial role in risk stratification and local tumor control.
  • Current Rhabdomyosarcoma treatment follows established protocols from the Children's Oncology Group.

More Related Videos

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...